"","RegisterNumber","RegisterYear","Product type","DrugType","Sub-Type","Scientific Name","Scientific Name Arabic","Trade Name","Trade Name Arabic","Strength","StrengthUnit","PharmaceuticalForm","AdministrationRoute","AtcCode1","AtcCode2","Size","SizeUnit","PackageTypes","PackageSize","Legal Status","Product Control","Distribute area","Public price","shelfLife","Storage conditions","Marketing Company","Marketing Country","Manufacture Name","Manufacture Country","2Manufacture Name","Manufacture Country...31","Secondry package  manufacture","Main Agent","Second Agent","Third agent","Marketing Status","Authorization Status","longitude","latitude"
"1","16-315-99",1999,"Human","NCE",NA,"IOHEXOL",NA,"OMNIPAQUE","<U+0627><U+0648><U+0645><U+0646><U+064A><U+0628><U+0627><U+0643>","350","mg/ml","INJECTION, SOLUTION","Intravenous","V08AB02",NA,100,"ml","Vial",10,"Prescription","Uncontrolled","Hospital",1894.25,36,"store below 25°c","GE HEALTHCARE","Ireland","Gulf Pharmaceutical Industries (Julphar)","United Arab Emirates","Gulf Pharmaceutical Industries (Julphar)","United Arab Emirates",NA,"ZIMMO TRADING ESTABLISHMENT","SAUDI ARABIAN DRUG STORE COMPANY","SAUDI ARABIAN DRUG STORE COMPANY","Marketed","Valid",53.847818,23.424076
"2","1-378-02",2002,"Human","NCE",NA,"DIGOXIN",NA,"LANIBOS 0.25MG-2ML INJ.",NA,"0.125","mg/ml","Solution","Intravenous","C01AA05",NA,2,"ml","Ampoule",10,"Prescription","Uncontrolled","Hospital",14.75,24,"store below 25°c","BOSNALIJEK PHARMACEUTICAL","Bosnia and Herzegovina","BOSNALIJEK PHARMACEUTICAL","Bosnia and Herzegovina","BOSNALIJEK PHARMACEUTICAL","Bosnia and Herzegovina",NA,"MANAYER NAJD TRADING MEDICAL NEEDS CO.","Annhdah Medical Company","Annhdah Medical Company","Marketed","Valid",17.679076,43.915886
"3","10-211-97",1997,"Human","NCE",NA,"GABAPENTIN",NA,"NEURONTIN","<U+0646><U+06CC><U+0648><U+0631><U+0648><U+0646><U+062A><U+06CC><U+0646>","400","mg","TABLET, FILM COATED","Oral","N03AX12",NA,0,NA,"Blister",100,"Prescription","Uncontrolled","Pharmacy",134.4,24,"store below 25°c","PFIZER","Germany","R-Pharm JSC","Russia","R-Pharm JSC","Russia",NA,"ALNAGHI COMPANY","Mansour Rabia Medical Co.","Mansour Rabia Medical Co.","Marketed","Valid",105.318756,61.52401
"4","16-205-98",1998,"Human","NCE",NA,"LEVONORGESTREL",NA,"MIRENA 52 MG INTRAUTERINE DELIVERY SYSTEM (IUS)","<U+0645><U+064A><U+0631><U+064A><U+0646><U+0627> 52 <U+0645><U+0644><U+062C><U+0645>","52","mg","INTRAUTERINE DEVICE","Vaginal","G03AC03",NA,0,NA,"Box",1,"Prescription","Uncontrolled","Pharmacy",379.6,36,"store below 25°c","BAYER OY","Finland","BAYER OY","Finland",NA,NA,NA,"Bayer Saudi Arabia","EBRAHIM M. ALMANA & BROS. CO.","EBRAHIM M. ALMANA & BROS. CO.","Marketed","Valid",25.748151,61.92411
"5","251-24-04",2004,"Human","NCE",NA,"CAPECITABINE",NA,"XELODA 500MG TABLET","<U+0643><U+0633><U+064A><U+0644><U+0648><U+062F><U+0627> 500 <U+0645><U+0644><U+062C><U+0645>","500","mg","Tablet","Oral","L01BC06",NA,0,NA,"Blister",120,"Prescription","Uncontrolled","Pharmacy",1305.3,36,NA,"ROCHE","Switzerland","PRODUCTOSE ROCHE , S.A. DE C.V","Mexico",NA,NA,NA,"ALNAGHI COMPANY",NA,NA,"Marketed","Valid",-102.552784,23.634501
"6","38-352-04",2004,"Human","Generic",NA,"CIPROFLOXACIN",NA,"CIFLOX 500MG TABLET","<U+0633><U+064A><U+0641><U+0644><U+0648><U+0643><U+0633> 500 <U+0645><U+0644><U+062C><U+0645>","500","mg","Tablet","Oral","J01MA02",NA,0,NA,"Blister",10,"Prescription","Uncontrolled","Pharmacy",37.45,36,"store below 25°c","KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES","Kuwait","KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES","Kuwait",NA,NA,NA,"ZIMMO TRADING ESTABLISHMENT",NA,NA,"Marketed","Valid",47.481766,29.31166
"7","37-237-98",1998,"Human","NCE",NA,"PACLITAXEL",NA,"ANZATAX 6MG-ML VIAL","<U+0623><U+0646><U+0632><U+0627><U+062A><U+0627><U+0643><U+0633> 6 <U+0645><U+0644><U+062C><U+0645>-<U+0645><U+0644>","6","mg/ml","Solution","Intravenous","L01CD01",NA,25,"ml","Vial",1,"Prescription","Uncontrolled","Hospital",796.15,24,"store below 25°c","HOSPIRA AUSTRALIA","Australia","HOSPIRA AUSTRALIA","Australia",NA,NA,NA,"PFIZER SAUDI LIMITED",NA,NA,"Marketed","Valid",133.775136,-25.274398
"8","5-724-11",2011,"Human","Generic",NA,"AMPICILLIN, SALBACTAM",NA,"AMPIPLUS 1.5GM POWDER FOR INGECTION","<U+0623><U+0645><U+0628><U+064A><U+0644><U+0633> 1.5 <U+0645><U+0644><U+062C><U+0645>","1000, 500","mg","POWDER, FOR SOLUTION","Parenteral","J01CR01",NA,1.5,"g","Vial",50,"Prescription","Uncontrolled","Hospital",752.5,24,"store below 25°c","ANTIBIOTIC S.E","Romania","ANTIBIOTIC S.E","Romania",NA,NA,NA,"AL HOBAIL MEDICAL OFFICE COMPANY LTD.",NA,NA,"Marketed","Valid",24.96676,45.943161
"9","26-367-14",2014,"Human","NCE",NA,"TERLIPRESSIN ACETATE",NA,"GLYPRESSIN 0.1 mg/ml solution for injection","<U+062C><U+0644><U+064A><U+0628><U+0631><U+064A><U+0633><U+064A><U+0646> 0.1 <U+0645><U+0644><U+062C><U+0645>/<U+0645><U+0644>","0.1","mg/ml","Solution","Intravenous","H01BA04",NA,8.5,"ml","Ampoule",5,"Prescription","Uncontrolled","Hospital",737.55,24,"store in a refrigerator (2°c – 8°c)","FERRING","Germany","ZENTIVA K.S.","Czech Republic",NA,NA,NA,"Abdulrehman Algosaibi G.T.C.",NA,NA,"Marketed","Valid",15.472962,49.817492
"10","299-11-13",2013,"Human","NCE",NA,"CANAKINUMAB",NA,"ILARIS 150MG","<U+0625><U+064A><U+0644><U+0627><U+0631><U+064A><U+0633>","150","mg","POWDER, FOR SOLUTION","Parenteral","L04AC08",NA,1,"ml","Vial",1,"Prescription","Uncontrolled","Hospital",43890.4,36,"store in a refrigerator (2°c – 8°c)","NOVARTIS","Switzerland","NOVARTIS","Switzerland",NA,NA,NA,"Novartis Saudi Limited",NA,NA,"Marketed","Valid",8.227512,46.818188
"11","2-684-16",2016,"Human","Generic",NA,"LETROZOLE",NA,"LETARA 2.5 mg tablet","<U+0644><U+064A><U+062A><U+0627><U+0631><U+0627> 2,5 <U+0645><U+0644><U+062C><U+0645>","2.5","mg","Tablet","Oral","L02BG04",NA,0,NA,"Single-dose container",30,"Prescription","Uncontrolled","Pharmacy",187.35,36,"do not store above 30°c","DOUGLAS MANUFACTURING Ltd","New Zealand","DOUGLAS MANUFACTURING Ltd","New Zealand",NA,NA,NA,"Thimar Aljazirah Company",NA,NA,"Marketed","Valid",174.885971,-40.900557
"12","11-832-17",2017,"Human","NCE",NA,"VANDETANIB",NA,"CAPRELSA 300 mg film-coated tablet","<U+0643><U+0627><U+0628><U+0631><U+064A><U+0644><U+0633><U+0627> <U+0663><U+0660><U+0660> <U+0645><U+0644><U+062C><U+0645>","300","mg","Film-Coated Tablet","Oral","L01XE12",NA,0,NA,"Blister",30,"Prescription","Uncontrolled","Pharmacy",20056.2,48,"store below 30°c","GENZYME EUROPE B.V.","Netherlands","IPR PHARMACEUTICALS INC.","Puerto Rico",NA,NA,NA,"Sanofi Arabia Trading Co. Ltd",NA,NA,"Marketed","Valid",-66.590149,18.220833
"13","65-100-15",2015,"Human","NCE",NA,"CATRIDECACOG",NA,"NovoThirteen (rFXIII) powder and solvent for solution for injection",NA,"2500","IU","POWDER, FOR SOLUTION","Intravenous","B02BD11",NA,0,NA,"Vial",1,"Prescription","Uncontrolled","Hospital",83063.45,24,"store in a refrigerator (2°c – 8°c)","NOVO NORDISK","Denmark","NOVO NORDISK","Denmark",NA,NA,NA,"Salehiya Trading Co.",NA,NA,"Marketed","Valid",9.501785,56.26392
"14","22-590-16",2016,"Human","Generic",NA,"SOFOSBUVIR",NA,"SOFOCURE 400 mg film-coated tablet","<U+0633><U+0648><U+0641><U+0648><U+0643><U+064A><U+0648><U+0631> 400 <U+0645><U+0644><U+062C><U+0645>","400","mg","TABLET, FILM COATED","Oral","J05AP08 ",NA,0,NA,"Tablet Container",28,"Prescription","Uncontrolled","Pharmacy",5600,24,"store below 30°c","BATTERJEE PHARMACETICAL FACTORY","Saudi Arabia","EUROPEAN EGYPTIAN PHARMACEUTICAL IND. CO","Egypt",NA,NA,NA,"BATTERJEE PHARMACEUTICAL FACTORY",NA,NA,"Marketed","Valid",30.802498,26.820553
"15","13-313-16",2016,"Human","NCE",NA,"FEBUXOSTAT",NA,"ADENURIC 80 mg film-coated tablet","<U+0623><U+062F><U+064A><U+0646><U+0648><U+0631><U+064A><U+0643> 80 <U+0645><U+0644><U+062C><U+0645>","80","mg","TABLET, FILM COATED","Oral","M04AA03",NA,0,NA,"Blister",28,"Prescription","Uncontrolled","Pharmacy",107.45,36,"do not store above 30°c","Algorithm SAL","Lebanon","Algorithm SAL","Lebanon",NA,NA,NA,"Salehiya Trading Co.",NA,NA,"Marketed","Valid",35.862285,33.854721
"16","150-9-18",2018,"Human","NCE",NA,"RIBOCICLIB",NA,"KISQALI 200 mg Film-Coated Tablet","<U+0643><U+06CC><U+0633><U+0643><U+0627><U+0644><U+064A> 200 <U+0645><U+0644><U+063A><U+0645> <U+0623><U+0642><U+0631><U+0627><U+0635> <U+0645><U+063A><U+0644><U+0641><U+0629>","200","mg","Film-Coated Tablet","Oral",NA,NA,0,NA,"Blister",63,"Prescription","Uncontrolled","Pharmacy",14671.95,36,"store below 30°c","NOVARTIS PHARMA AG","Switzerland","NOVARTIS SINGAPORE PHARMACEUTICAL MANUFACTURING PTE. LTD.","Singapore",NA,NA,NA,"Novartis Saudi Limited",NA,NA,"Marketed","Valid",103.819836,1.352083
"17","31-809-18",2018,"Human","Generic",NA,"AMLODIPINE BESYLATE",NA,"AMEP 10 mg Tablet","<U+0623><U+0645><U+064A><U+0628> 10 <U+0645><U+0644><U+062C><U+0645>","10","mg","Tablet","Oral","C08CA01",NA,0,NA,"Blister",56,"Prescription","Uncontrolled","Pharmacy",54.4,36,"store below 30°c","COOPER PHARMA","Morocco","COOPER PHARMA","Morocco",NA,NA,NA,"ZIMMO TRADING ESTABLISHMENT","ARAC HEALTHCARE","ARAC HEALTHCARE","Marketed","Valid",-7.09262,31.791702
"18","278-334-18",2018,"Human","Generic",NA,"BORTEZOMIB","<U+0628><U+0648><U+0631><U+062A><U+064A><U+0632><U+0648><U+0645><U+064A><U+0628>","VEELBORE 3.5 mg Powder For Solution For Injection",NA,"3.5","mg","POWDER, FOR SOLUTION","Subcutaneous","L01XX32",NA,8,"ml","Vial",1,"Prescription","Uncontrolled","Hospital",2692.85,36,"store below 30°c","Jazeera Pharmaceutical Industries (JPI)","Saudi Arabia","PharmIdea SIA","Latvia",NA,NA,NA,"Jazeera Pharmaceutical Industries (JPI)",NA,NA,"Marketed","Valid",24.603189,56.879635
"19","13-807-18",2018,"Human","Biological","Biosimilar","FILGRASTIM",NA,"NIVESTIM 960 mcg Solution for Injection/ Infusion",NA,"960","µg/ml","Solution","Intravenous","L03AA02",NA,0.5,"ml","Pre-filled syringe",5,"Prescription","Uncontrolled","Hospital",1513.6,30,"store in a refrigerator (2°c – 8°c)","HOSPIRA UK LIMITED","United Kingdom","HOSPIRA ZAGREB D.O.O.","Croatia",NA,NA,NA,"PFIZER SAUDI LIMITED",NA,NA,"Marketed","Valid",15.2,45.1
"20","296-24-18",2018,"Human","Biological",NA,"EMICIZUMAB",NA,"HEMLIBRA 150 MG/ML SOLUTION FOR INJECTION","<U+0647><U+064A><U+0645><U+0644><U+064A><U+0628><U+0631><U+0627>  150 <U+0645><U+0644><U+062C><U+0645> /<U+0645><U+0644> <U+0645><U+062D><U+0644><U+0648><U+0644> <U+0644><U+0644><U+062D><U+0642><U+0646>","150","mg/ml","Solution","Subcutaneous","B02BX06",NA,1,"ml","Vial",1,"Prescription","Uncontrolled","Pharmacy",52475.75,30,"store in a refrigerator (2°c – 8°c)","ROCHE","Switzerland","CHUGAI PHARMACEUTICAL CO LTD","Japan",NA,NA,NA,"ALNAGHI COMPANY",NA,NA,"Marketed","Valid",138.252924,36.204824
"21","23-698-17",2017,"Human","NCE",NA,"SUGAMMADEX",NA,"BRIDION 100 MG/ML SOLUTION FOR INJECTION","<U+0628><U+0631><U+064A><U+062F><U+0648><U+064A><U+0646> 100 <U+0645><U+0644><U+062C><U+0645> / <U+0645><U+0644>","100","mg/ml","Solution","Intravenous","V03AB35",NA,5,"ml","Vial",10,"Prescription","Uncontrolled","Hospital",7260.9,36,"store below 30°c","MERCK SHARP & DOHME LIMITED","United Kingdom","Merck Sharp & Dohme B.V. Legal Entity N.V. Organon.","Netherlands",NA,NA,NA,"Farouk, Maamoun Tamer & CO",NA,NA,"Marketed","Valid",5.291266,52.132633
"22","86-370-18",2018,"Human","Generic",NA,"EXEMESTANE",NA,"XEMETAN 25MG F.C.TABLET","<U+0632><U+064A><U+0645><U+064A><U+062A><U+0627><U+0646>","25","mg","TABLET, COATED","Oral","L02BG06",NA,0,NA,"Blister",30,"Prescription","Uncontrolled","Pharmacy",88.85,24,"store below 30°c","SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO","Saudi Arabia","OMAN PHARMACEUTICAL PRODUCTS","Oman",NA,NA,NA,"Saudi Arabian Japanese Pharmaceutical Co. Ltd.",NA,NA,"Marketed","Valid",55.923255,21.512583
"23","364-212-17",2017,"Human","Generic",NA,"LEVETIRACETAM",NA,"LEVETAM 500 mg film-coated tablet","<U+0644><U+064A><U+0641><U+064A><U+062A><U+0627><U+0645> <U+0665><U+0660><U+0660> <U+0645><U+0644><U+062C><U+0645>","500","mg","TABLET, FILM COATED","Oral","N03AX14",NA,0,NA,"Blister",30,"Prescription","Uncontrolled","Pharmacy",93.3,24,"store below 30°c","SPIMACO","Saudi Arabia","ACTAVIS","Iceland",NA,NA,"SPIMACO","SPIMACO",NA,NA,"Marketed","Valid",-19.020835,64.963051
"24","98-15-17",2017,"Human","NCE",NA,"OSIMERTINIB MESYLATE",NA,"TAGRISSO 40 mg Film-Coated Tablet","<U+062A><U+0627><U+062C><U+0631><U+064A><U+0633><U+0648> <U+0664><U+0660> <U+0645><U+0644><U+062C><U+0645>","40","mg","TABLET, FILM COATED","Oral","L01XE35",NA,0,NA,"Blister",30,"Prescription","Uncontrolled","Hospital",29905.2,36,"store below 30°c","AstraZeneca","Sweden","AstraZeneca","Sweden",NA,NA,NA,"ALNAGHI COMPANY",NA,NA,"Marketed","Valid",18.643501,60.128161
"25","99-15-17",2017,"Human","NCE",NA,"OSIMERTINIB MESYLATE",NA,"TAGRISSO 80 mg Film-Coated Tablet","<U+062A><U+0627><U+062C><U+0631><U+064A><U+0633><U+0648> <U+0668><U+0660> <U+0645><U+0644><U+062C><U+0645>","80","mg","TABLET, FILM COATED","Oral","L01XE35",NA,0,NA,"Blister",30,"Prescription","Uncontrolled","Hospital",29905.2,36,"store below 30°c","AstraZeneca","Sweden","AstraZeneca","Sweden",NA,NA,NA,"ALNAGHI COMPANY",NA,NA,"Marketed","Valid",18.643501,60.128161
"26","85-370-18",2018,"Human","Generic",NA,"FINGOLIMOD HCL",NA,"FEGONA 0.5 MG CAPSULE","<U+0641><U+064A><U+062C><U+0648><U+0646><U+0627> <U+0660>,<U+0665> <U+0645><U+0644><U+062C><U+0645>","0.5","mg","Capsule","Oral","L04AA27",NA,0,NA,"Blister",28,"Prescription","Uncontrolled","Pharmacy",4806.25,24,"store below 25°c","SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO","Saudi Arabia","BLUEPHARMA INDUSTRIA FARMACEUTICA, S.A","Portugal",NA,NA,"Saudi Arabian Japanese Pharmaceutical Co. (SAJA)","Saudi Arabian Japanese Pharmaceutical Co. Ltd.",NA,NA,"Marketed","Valid",-8.224454,39.399872
"27","14-560-19",2019,"Human","Generic",NA,"REMIFENTANIL HYDROCHLORIDE",NA,"REMIFENTANIL MEDIS 5 MG VIAL","<U+0631><U+064A><U+0645><U+064A><U+0641><U+064A><U+0646><U+062A><U+0627><U+0646><U+064A><U+0644> <U+0645><U+064A><U+062F><U+064A><U+0633> 5 <U+0645><U+0644><U+062C><U+0645>","5","mg","POWDER, FOR SOLUTION","Intravenous","N01AH06",NA,0,NA,"Vial",5,"Prescription","Controlled","Hospital",306.05,24,"store below 25°c","LES LABORATOIRES MEDIS","Tunisia","LES LABORATOIRES MEDIS","Tunisia",NA,NA,NA,"Salehiya Trading Co.",NA,NA,"Marketed","Valid",9.537499,33.886917
"28","1-755-18",2018,"Human","Generic",NA,"HEPARIN SODIUM",NA,"HEPARINOL 5000 IU/ML INJECTION","<U+0647><U+064A><U+0628><U+0627><U+0631><U+064A><U+0646><U+0648><U+0644>  5000 <U+0648><U+062D><U+062F><U+0629> <U+062F><U+0648><U+0644><U+064A><U+0629>/ <U+0645><U+0644> <U+062D><U+0642><U+0646>","5000","IU/ml","INJECTION, SOLUTION","SUBCUTANEOUS, INTRAVENOUS","B01AB01 ",NA,5,"ml","Vial",10,"Prescription","Uncontrolled","Hospital",317.4,36,"store below 30°c","AIN MEDICARE SDN. BHD.","Malaysia","AIN MEDICARE SDN. BHD.","Malaysia",NA,NA,NA,"AL EWAN MEDICAL COMPANY",NA,NA,"Marketed","Valid",101.975766,4.210484
"29","2-5438-20",2020,"Human","Generic",NA,"GEMCITABINE","<U+062C><U+064A><U+0645><U+0633><U+064A><U+062A><U+0627><U+0628><U+064A><U+0646>","GEMCITABINE GLENMARK 1000MG VIAL","<U+062C><U+064A><U+0645><U+0633><U+064A><U+062A><U+0627><U+0628><U+064A><U+0646> <U+062C><U+0644><U+064A><U+0646><U+0645><U+0627><U+0631><U+0643>","1000","mg","lyophilisate for solution for injection","Intravenous","L01BC05",NA,50,"ml",NA,1,"Prescription","Uncontrolled","Hospital",94.35,24,"store below 30°c","GLENMARK GENERIC SA","Argentina","GLENMARK GENERIC SA","Argentina",NA,NA,NA,"Salehiya Trading Co.",NA,NA,"Marketed","Valid",-63.616672,-38.416097
"30","3-5334-19",2019,"Human","NCE",NA,"CARGLUMIC ACID",NA,"CARBAGLU 200MG DISPERSIBLE TABLETS","<U+0643><U+0627><U+0631><U+0628><U+0627><U+063A><U+0644><U+0648> <U+0662><U+0660><U+0660> <U+0645><U+0644><U+062C><U+0645>","200","mg","Tablet","Oral","A16AA05",NA,0,NA,"Bottle",60,"Prescription","Uncontrolled","Pharmacy",16486.8,36,"store in a refrigerator (2°c – 8°c)","Recordati Rare Diseases","France","Laboratoires BTT","France",NA,NA,NA,"ZIMMO TRADING ESTABLISHMENT",NA,NA,"Marketed","Valid",2.213749,46.227638
"31","68-4-19",2019,"Human","Radiopharmaceutical",NA,"RADIUM-223 CHLORIDE",NA,"XOFIGO 1100 kBq/ml Solution for Injection","<U+0632><U+0648><U+0641><U+064A><U+062C><U+0648>","1100","kBq/ml","solution for injection","Intravenous",NA,NA,6,"ml","Vial",1,"Prescription","Uncontrolled","Hospital",22054.2,1,NA,"BAYER AG","Germany","INSTITUTE FOR ENERGY TECHNOLOGY (IFE)","Norway",NA,NA,NA,"Abdulla Fouad Holding Co.",NA,NA,"Marketed","Valid",8.468946,60.472024
"32","0504200048",2020,"Human","Generic",NA,"SODIUM HYALURONATE","<U+0647><U+064A><U+0627><U+0644><U+0648><U+0631><U+0648><U+0646><U+0627><U+062A> <U+0627><U+0644><U+0635><U+0648><U+062F><U+064A><U+0648><U+0645>","Pluryal VOLUME","<U+0628><U+0644><U+0648><U+0631><U+064A><U+0627><U+0644> <U+0641><U+0648><U+0644><U+064A><U+0645>","23","mg/ml","injection","Intradermal","M09AX01",NA,1,"ml","Pre-filled syringe",1,"Prescription","Uncontrolled","Pharmacy",352.25,36,"store below 25°c","MD SKIN SOLUTIONS","Luxembourg","MD SKIN Solutions","Luxembourg",NA,NA,NA,"Beauty Med",NA,NA,"Marketed","Valid",6.129583,49.815273
"33","113-370-20",2020,"Human","Generic",NA,"LENALIDOMIDE","<U+0644><U+064A><U+0646><U+0627><U+0644><U+064A><U+062F><U+0648><U+0645><U+064A><U+062F>","LIDOVA 25 mg capsule","<U+0644><U+064A><U+062F><U+0648><U+0641><U+0627> 25 <U+0645><U+0644><U+062C><U+0645>","25","mg","capsule, hard","Oral","L04AX04",NA,0,NA,"Blister",21,"Prescription","Uncontrolled","Hospital",13611.5,36,"store below 30°c","SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO","Saudi Arabia","LOTUS PHARMACEUTICAL CO., LTD","Taiwan",NA,NA,"Saudi Arabian Japanese Pharmaceutical Co. (SAJA)","Saudi Arabian Japanese Pharmaceutical Co. Ltd.",NA,NA,"Marketed","Valid",120.960515,23.69781
"34","1603200040",2020,"Human","Biological",NA,"Voretigene Neparvovec",NA,"Luxturna","<U+0644><U+0648><U+0643><U+0633><U+062A><U+0648><U+0631><U+0646><U+0627>","5e+12",NA,NA,NA,NA,NA,0,NA,"Vial",3,"Prescription","Uncontrolled","Hospital",1759274.324,24,NA,"Novartis Europharm Limited","Ireland","Nova Laboratories Ltd","United Kingdom",NA,NA,NA,"Novartis Saudi Limited",NA,NA,"Marketed","Valid",-3.435973,55.378051
"35","301-334-19",2019,"Human","Generic",NA,"SUNITINIB",NA,"RENIS 50MG CAPSULE","<U+0631><U+064A><U+0646><U+064A><U+0633>","50","mg","Capsule","Oral","L01XE04",NA,0,NA,"Blister",30,"Prescription","Uncontrolled","Hospital",15677.45,36,"store below 30°c","Jazeera Pharmaceutical Industries (JPI)","Saudi Arabia","THE ARAB PHARMACEUTICAL MANUFACTURING PSC","Jordan",NA,NA,NA,"Jazeera Pharmaceutical Industries (JPI)",NA,NA,"Marketed","Valid",36.238414,30.585164
"36","42-5286-20",2020,"Human","Generic",NA,"SUNITINIB MALEATE",NA,"SUTEXA 50MG CAPSULE",NA,"50","mg","hard capsule","Oral","L01XE04",NA,0,NA,"Blister",30,"Prescription","Uncontrolled","Hospital",14109.7,24,"store below 30°c","MS Pharma Saudi (MSPS)","Saudi Arabia","Combino Pharm (Malta) Ltd","Malta",NA,NA,"MS Pharma Saudi","Cigalah Group",NA,NA,"Marketed","Valid",14.375416,35.937496
"37","9-961-19",2019,"Human","NCE",NA,"NUSINERSEN","<U+0646><U+0648><U+0633><U+064A><U+0646><U+0631><U+0633><U+064A><U+0646>","SPINRAZA 2.4 mg/ml Vial","<U+0633><U+0628><U+064A><U+0646><U+0631><U+0627><U+0632><U+0627>","12","mg","solution for injection","INTRATHECAL","M09AX",NA,5,"ml","Vial",1,"Prescription","Uncontrolled","Hospital",394762.5,36,"store in a refrigerator (2°c – 8°c)","Biogen Idec Ltd","United Kingdom","Patheon Italia S.P.A.","Italy",NA,NA,NA,"Salehiya Trading Co.",NA,NA,"Marketed","Valid",12.56738,41.87194
"38","1-5477-20",2020,"Human","Biological",NA,"ALEMTUZUMAB",NA,"LEMTRADA 12 MG CONCENTRATE FOR SOLUTION FOR INFUSION",NA,"12","mg","INJECTION, SOLUTION, CONCENTRATE","Intravenous","L04AA",NA,1.2,"ml","Vial",1,"Prescription","Uncontrolled","Hospital",32921.25,36,"store in a refrigerator (2°c – 8°c)","Sanofi Belgium","Belgium","Boehringer Ingelheim Pharma GmbH & Co. KG","Germany",NA,NA,NA,"Sanofi Arabia Trading Co. Ltd",NA,NA,"Marketed","Valid",10.451526,51.165691
"39","5-5356-19",2019,"Human","Biological","Blood product","HUMAN NORMAL IMMUNOGLOBULIN","<U+062C><U+0644><U+0648><U+0628><U+06CC><U+0648><U+0644><U+06CC><U+0646> <U+0645><U+0646><U+0627><U+0639><U+064A> <U+0628><U+0634><U+0631><U+064A> <U+063A><U+06CC><U+0631> <U+0646><U+0648><U+0639><U+064A>","HYQVIA 100MG/ML SOLUTION FOR INFUSION","<U+0645><U+062D><U+0644><U+0648><U+0644> <U+06BE><U+0627><U+06CC><U+0643><U+0648><U+06A4><U+06CC><U+0627> 100 <U+0645><U+0644><U+062C><U+0645>/<U+0645><U+0644> <U+0644><U+0644><U+062D><U+0642><U+0646> <U+062A><U+062D><U+062A> <U+0627><U+0644><U+062C><U+0644><U+062F>","10","%","solution for infusion","Subcutaneous","J06BA",NA,300,"ml","Vial",1,"Prescription","Uncontrolled","Hospital",8060.55,36,NA,"Baxalta Innovations GmbH","Austria","Baxalta Belgium Manufacturing SA","Belgium",NA,NA,NA,"Arabian Health Care Co.",NA,NA,"Marketed","Valid",4.469936,50.503887
"40","2207200115",2020,"Human","NCE","New Chemical Entity","alpelisib",NA,"piqray","<U+0628><U+064A><U+0643><U+0631><U+0627><U+064A>","200","mg","Film-Coated Tablet","Oral",NA,NA,NA,NA,"Blister",28,"Prescription","Uncontrolled","Hospital",17606.34,24,"Store below 30°C , Protect from light and moisture","NOVARTIS PHARMA SCHWEIZ AG","Switzerland","LEK PHARMACEUTICAL D.D","Slovenia","LEK PHARMACEUTICAL D.D","Slovenia",NA,"Novartis Saudi Limited",NA,NA,"Marketed","Valid",14.995463,46.151241
"41","2207200119",2020,"Human","NCE","New Chemical Entity","Alpelisib",NA,"piqray","<U+0628><U+064A><U+0643><U+0631><U+0627><U+064A>","200 , 50","mg","Film-coated cablet","Oral",NA,NA,NA,NA,"Blister",56,"Prescription","Uncontrolled","Hospital",17606.34,24,"Store below 30°C , Protect from light and moisture","NOVARTIS PHARMA SCHWEIZ AG","Switzerland","Lek Pharmaceuticals, d.d.","Slovenia","Lek Pharmaceuticals, d.d.","Slovenia",NA,"Novartis Saudi Limited",NA,NA,"Marketed","Valid",14.995463,46.151241
"42","1-5311-19",2019,"Human","Biological","Biological","CANAKINUMAB",NA,"ILARIS",NA,"150","mg/ml","solution for injection","Subcutaneous","L04AC08",NA,1,"ml","Vial",1,"Prescription","Uncontrolled","Hospital",43890.4,24,"Store in a refrigerator (2°C – 8°C), do not freeze","Novartis Europharm Limited","Ireland","NOVARTIS Pharma Stein AG","Switzerland",NA,NA,NA,"Novartis Saudi Limited",NA,NA,"Marketed","Valid",8.227512,46.818188
"43","15-832-18",2018,"Human","NCE","New Chemical Entity","ELIGLUSTAT",NA,"CERDELGA",NA,"84","mg","capsule, hard","Oral","A16AX10",NA,NA,NA,"Blister",56,"Prescription","Uncontrolled","Hospital",95189.65,36,"store below 30°c","GENZYME EUROPE B.V.","Netherlands","GENZYME IRELAND LIMITED","Ireland",NA,NA,NA,"Sanofi Arabia Trading Co. Ltd",NA,NA,"Marketed","Valid",-8.24389,53.41291
"44","2110200234",2020,"Human","Biological","Other","Tisagenlecleucel",NA,"Kymriah","<U+0643><U+064A><U+0645><U+0631><U+0627><U+064A><U+0627>","6",NA,"Dispersion for infusion","Intravenous",NA,NA,1,"ml","Bag",1,"Prescription","Uncontrolled","Hospital",1633500,9,"Store at temperatures below -140°C in the vapour phase of liquid nitrogen","Novartis Europharm Limited","Ireland","NOVARTIS","United States",NA,NA,NA,"Novartis Saudi Limited",NA,NA,"Marketed","Valid",-95.712891,37.09024
"45","1-5401-20",2020,"Human",NA,NA,"CABAZITAXEL",NA,"NEUTAXAN",NA,"60","mg","concentrate for solution for infusion","Intravenous","L01CD04",NA,1.5,"ml","Vial",1,"Prescription","Uncontrolled","Hospital",5591.25,36,"store below 30°c","GENSENTA ILAÇ SANAYI VE TICARET A.S","Turkey","Gensenta Ilaç Sanayi ve Ticaret A.S","Turkey",NA,NA,NA,"Salehiya Trading Co.",NA,NA,"Marketed","Valid",35.243322,38.963745
"46","0810200207",2020,"Human","Generic",NA,"Pomalidomide",NA,"Pomalidomide SPC",NA,"3","mg","Capsule","Oral","L04AX06",NA,NA,NA,"Blister",21,"Prescription","Uncontrolled","Hospital",23588.049,24,"store below 30°c","SUDAIR PHARMA COMPANY","Saudi Arabia","Dr. Reddy’s Laboratories Ltd. Formulation Unit VII","India","Dr. Reddy’s Laboratories Ltd. Formulation Unit VII","India","Sudair Pharma Company","SUDAIR PHARMA COMPANY",NA,NA,"Marketed","Valid",78.96288,20.593684
"47","0810200197",2020,"Human","Generic",NA,"Pomalidomide",NA,"Pomalidomide SPC",NA,"4","mg","Capsule","Oral","L04AX06",NA,NA,NA,"Blister",21,"Prescription","Uncontrolled","Hospital",23588.049,24,"store below 30°c","SUDAIR PHARMA COMPANY","Saudi Arabia","Sudair Pharma Company","Saudi Arabia","Sudair Pharma Company","Saudi Arabia","Sudair Pharma Company","SUDAIR PHARMA COMPANY",NA,NA,"Marketed","Valid",45.079162,23.885942
"48","0810200198",2020,"Human","Generic",NA,"Pomalidomide",NA,"Pomalidomide SPC","<U+0628><U+0648><U+0645><U+0627><U+0644><U+064A><U+062F><U+0648><U+0645><U+064A><U+062F> <U+0627><U+0633> <U+0628><U+064A> <U+0633><U+064A>","3","mg","Capsule","Oral","L04AX06",NA,NA,NA,"Bottle",21,"Prescription","Uncontrolled","Hospital",23588.049,24,"store below 30°c","SUDAIR PHARMA COMPANY","Saudi Arabia","Dr. Reddy’s Laboratories Ltd. Formulation Unit VII","India","Dr. Reddy’s Laboratories Ltd. Formulation Unit VII","India","Sudair Pharma Company","SUDAIR PHARMA COMPANY",NA,NA,"Marketed","Valid",78.96288,20.593684
"49","0810200205",2020,"Human","Generic",NA,"Pomalidomide",NA,"Pomalidomide SPC",NA,"4","mg","Capsule","Oral","L04AX06",NA,NA,NA,"Bottle",21,"Prescription","Uncontrolled","Hospital",23588.049,36,"store below 30°c","SUDAIR PHARMA COMPANY","Saudi Arabia","Sudair Pharma Company","Saudi Arabia","Sudair Pharma Company","Saudi Arabia","Sudair Pharma Company","SUDAIR PHARMA COMPANY",NA,NA,"Marketed","Valid",45.079162,23.885942
"50","13-174-20",2020,"Human","Generic",NA,"CISATRACURIUM BESILATE",NA,"CIS-TAC",NA,"2","mg/ml","solution for injection/infusion","Intravenous","M03AC11",NA,5,"ml","Ampoule",5,"Prescription","Uncontrolled","Hospital",68.9,24,"store in a refrigerator (2°c – 8°c)","Fresenius Kabi Deutschland GmbH","Germany","Fresenius Kabi manufacturing SA (Pty) Ltd","South Africa",NA,NA,NA,"Faisal Musaed El Seif Saudi Pharmaceutical Co.","ALHAYA MEDICAL CO.","ALHAYA MEDICAL CO.","Marketed","Valid",22.937506,-30.559482
"51","1111200261",2020,"Human","Generic",NA,"DASATINIB","<U+062F><U+0627><U+0633><U+0627><U+062A><U+064A><U+0646><U+064A><U+0628>","DASATINIB SPC","<U+062F><U+0627><U+0633><U+0627><U+062A><U+064A><U+0646><U+064A><U+0628> <U+0625><U+0633> <U+0628><U+064A> <U+0633><U+064A>","140","mg","Film-Coated Tablet","Oral","L01XE06",NA,NA,NA,"Blister",30,"Prescription","Uncontrolled","Hospital",8541.4,24,"do not store above 30°c","SUDAIR PHARMA COMPANY","Saudi Arabia","Synthon Hispania SL","Spain",NA,NA,"Sudair Pharma Company","SUDAIR PHARMA COMPANY",NA,NA,"Marketed","Valid",-3.74922,40.463667
"52","2611200295",2020,"Human","Generic","Other","Erlotinib",NA,"Tyrox","<U+062A><U+0627><U+064A><U+0631><U+0648><U+0643><U+0633>","150","mg","Film-Coated Tablet","Oral","L01XE03",NA,NA,NA,"Blister",30,"Prescription","Uncontrolled","Hospital",4986.85,24,"store below 30°c","MS Pharma Saudi (MSPS)","Saudi Arabia","REMEDICA","Cyprus","REMEDICA","Cyprus","MS Pharma Saudi","Cigalah Group",NA,NA,"Marketed","Valid",33.429859,35.126413
"53","3011200300",2020,"Human","Generic","Other","Bosentan monohydrate",NA,"Bosentan OHRE Pharma","<U+0628><U+0648><U+0633><U+0646><U+062A><U+0627><U+0646> <U+0623><U+0648><U+0631><U+064A> <U+0641><U+0627><U+0631><U+0645><U+0627>","62.5","mg","Film-Coated Tablet","Oral","C02KX01",NA,NA,NA,"Blister",56,"Prescription","Uncontrolled","Pharmacy",5504.1,36,"store below 30°c","OHRE Pharma","France","PHARMACEUTICAL WORKS POLPHARMA S.A.","Poland",NA,NA,NA,"QOMEL MEDICAL DRUG STORE",NA,NA,"Marketed","Valid",19.145136,51.919438
"54","80-5286-20",2021,"Human","Generic",NA,"PEMETREXED",NA,"ALMETRA",NA,"500","mg","powder for concentrate for solution for infusion","Intravenous","L01BA04",NA,NA,NA,"Vial",1,"Prescription","Uncontrolled","Hospital",2595.15,36,"store below 30°c","MS Pharma Saudi (MSPS)","Saudi Arabia","Jiangsu Hengrui Medicine Co., Ltd","China",NA,NA,NA,"Cigalah Group",NA,NA,"Marketed","Valid",104.195397,35.86166
"55","2801210480",2021,"Human","NCE","New Chemical Entity","BRIGATINIB",NA,"ALUNBRIG","<U+0623><U+0644><U+0648><U+0646><U+0628><U+0631><U+064A><U+063A>","180","mg","Film-Coated Tablet","Oral","L01XE43",NA,NA,NA,"Blister",28,"Prescription","Uncontrolled","Hospital",19586.1,36,"store below 30°c","TAKEDA PHARMA A/S","Denmark","TAKEDA AUSTRIA GmbH","Austria","TAKEDA AUSTRIA GmbH","Austria",NA,"Abdulrehman Algosaibi G.T.C.",NA,NA,"Marketed","Valid",14.550072,47.516231
"56","1-5408-19",2021,"Human","NCE","New Chemical Entity","PONATINIB",NA,"ICLUSIG",NA,"45","mg","Film-Coated Tablet","Oral","L01XE",NA,NA,NA,"Bottle",30,"Prescription","Uncontrolled","Hospital",24559,36,"store below 30°c","ARIAD Pharmaceuticals, Inc","United States","PATHEON INC","Canada",NA,NA,NA,"Salehiya Trading Co.",NA,NA,"Marketed","Valid",-106.346771,56.130366
"57","2605210756",2021,"Human","Generic",NA,"FINGOLIMOD",NA,"Golimara","<U+062C><U+0648><U+0644><U+064A><U+0645><U+0627><U+0631><U+0627>","0.5","mg","capsule, hard","Oral","L04AA27",NA,NA,NA,"Blister",28,"Prescription","Uncontrolled","Hospital",4436.55,24,"do not store above 30°c","SPIMACO","Saudi Arabia","PHARMATHEN INTERNATIONAL","Greece","PHARMATHEN INTERNATIONAL","Greece",NA,"SPIMACO",NA,NA,"Marketed","Valid",21.824312,39.074208
"58","1904210686",2021,"Human","Biological","Biosimilar","TERIPARATIDE",NA,"TERROSA","<U+062A><U+064A><U+0631><U+0648><U+0633><U+0627>","20","µg","solution for injection in cartridge","Subcutaneous","H05AA02",NA,2.4,"ml","Pre-filled pen",1,"Prescription","Uncontrolled","Pharmacy",1003.05,24,"Store in a refrigerator (2°C – 8°C), do not freeze","TABUK PHARMACEUTICAL MANUFACTURING CO.","Saudi Arabia","GEDEON RICHTER PLC.","Hungary",NA,NA,NA,"Tabuk Pharmaceutical Manufacturing Company",NA,NA,"Marketed","Valid",19.503304,47.162494
"59","352-334-20",2020,"Human","Biological","Biosimilar","TRASTUZUMAB",NA,"HERZUMA 150MG VIAL",NA,"440","mg","powder for concentrate for solution for infusion","Intravenous","L01XC03",NA,50,"ml","Vial",1,"Prescription","Uncontrolled","Hospital",4003.1,36,"store in a refrigerator (2°c – 8°c)","Jazeera Pharmaceutical Industries (JPI)","Saudi Arabia","CELLTRION INC","South Korea",NA,NA,NA,"Jazeera Pharmaceutical Industries (JPI)",NA,NA,"Marketed","Valid",127.766922,35.907757
"60","2206210818",2021,"Human","Generic",NA,"PROPOFOL",NA,"Novfol",NA,"10","mg","emulsion for infusion","Intravenous","N01AX10",NA,20,"ml","Vial",5,"Prescription","Uncontrolled","Hospital",85.1,24,"store below 30°c","PT. Novell Pharmaceutical Laboratories","Indonesia","PT. Novell Pharmaceutical Laboratories","Indonesia",NA,NA,NA,"Girgas Trading Establishment",NA,NA,"Marketed","Valid",113.921327,-0.789275
